Rezulin was a drug used to treat type 2 diabetes until March 2000 when it was recalled. Rezulin was intended to help patients with type 2 diabetes who needed to regulate their insulin and blood sugar levels. Approved by the Food and Drug Administration (FDA) in 1997, its potentially deadly effects on the liver were known for some time.
A lack of viable alternatives for treating patients with diabetes kept Rezulin on the market despite its questionable safety record. It was the approval of two new diabetes drugs, both with safety profiles superior to Rezulin that finally incited Rezulin's withdrawal. The FDA requested that the drug's manufacturer, Parke-Davis/Warner-Lambert, stop sales of Rezulin, and the company complied with the request.
Liver damage is a serious condition, which can result in organ transplant or even death. If you, or a loved one, have suffered liver damage as the result of taking Rezulin, please contact us today.